| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 PCDH12 SVEP1 RYR3 EHD4 CPNE6 DST EEF2K PLCD1 PLA2G4F DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CRB1 PCDHB18P THBS1 PCDHGA12 ASPH MACF1 PCDH7 AGRN PCDHGA8 | 1.49e-06 | 749 | 257 | 27 | GO:0005509 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CHL1 DCHS2 CEACAM6 PCDH12 CNTN5 NECTIN4 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 ROBO1 PCDH7 PCDHGA8 | 2.78e-12 | 187 | 259 | 19 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CHL1 CYLD DCHS2 PDGFRA RC3H1 TNFRSF14 CEACAM6 NCAM2 PCDH12 IL1RL2 SVEP1 CNTN5 NECTIN4 DLG2 COL14A1 AFDN ZC3H12A ITCH ANK3 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 RELA YES1 CRB1 PCDHB18P THBS1 PCDHGA12 TJP1 CSTA ROBO1 PDE5A PCDH7 PCDHGA8 | 2.44e-09 | 1077 | 259 | 39 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 DCHS2 CEACAM6 PCDH12 CNTN5 NECTIN4 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 CRB1 PCDHB18P PCDHGA12 ROBO1 PCDH7 PCDHGA8 | 3.11e-09 | 313 | 259 | 20 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | RELN MAP1B GH1 PTPRA TRPV2 AFDN EEF2K ADGRL2 PLXNA1 FLT1 RELA FXN ADNP MACF1 ROBO1 SPEN AGRN | 2.36e-05 | 418 | 259 | 17 | GO:0051962 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 RELN ATP7A MAP1B MYCBP2 LHX9 DST SEMA5B CNTN5 TRPV2 ARC AFDN EEF2K PLXNA1 ANK3 LAMC1 FXN ADNP PREX2 TNN MACF1 ROBO1 AGRN PHACTR1 | 2.68e-05 | 748 | 259 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CHL1 RELN ATP7A MAP1B MYCBP2 LHX9 CPNE6 DST SEMA5B CNTN5 TRPV2 ARC AFDN EEF2K PLXNA1 ANK3 LAMC1 FXN ADNP PREX2 TNN MACF1 ROBO1 AGRN PHACTR1 | 2.92e-05 | 802 | 259 | 25 | GO:0048812 |
| GeneOntologyBiologicalProcess | developmental cell growth | MAP1B CPNE6 SEMA5B TRPV2 COL14A1 AFDN PLXNA1 AKAP6 FXN ADNP TNN CST4 MACF1 ROBO1 | 2.95e-05 | 301 | 259 | 14 | GO:0048588 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | RELN PDGFRA TNFRSF14 EHD4 GH1 PLCG2 ADNP YES1 IGHM CSPG4 AGRN | 3.44e-05 | 193 | 259 | 11 | GO:0050731 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 RELN ATP7A MAP1B MYCBP2 LHX9 CPNE6 DST SEMA5B CNTN5 TRPV2 ARC AFDN EEF2K PLXNA1 ANK3 LAMC1 FXN ADNP PREX2 TNN MACF1 ROBO1 AGRN PHACTR1 | 4.11e-05 | 819 | 259 | 25 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | RELN MAP1B GH1 PTPRA TRPV2 AFDN EEF2K PLXNA1 FLT1 RELA FXN ADNP MACF1 ROBO1 SPEN | 4.49e-05 | 354 | 259 | 15 | GO:0050769 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 RELN ATP7A MAP1B MYCBP2 LHX9 CPNE6 DST SEMA5B CNTN5 TRPV2 ARC AFDN EEF2K PLXNA1 ANK3 LAMC1 FXN ADNP PREX2 TNN MACF1 ROBO1 AGRN PHACTR1 | 4.72e-05 | 826 | 259 | 25 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection extension | MAP1B CPNE6 SEMA5B TRPV2 AFDN PLXNA1 FXN ADNP TNN MACF1 ROBO1 | 6.49e-05 | 207 | 259 | 11 | GO:1990138 |
| GeneOntologyBiologicalProcess | developmental growth | MAP1B PDGFRA MYCBP2 DAXX CHEK1 GH1 SETDB1 CPNE6 SEMA5B TRPV2 COL14A1 AFDN MED12 PLXNA1 AKAP6 FOXS1 COL6A1 FXN ADNP THBS1 TNN CST4 MACF1 ROBO1 MAEL AGRN | 8.71e-05 | 911 | 259 | 26 | GO:0048589 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | MAP1B CPNE6 SEMA5B TRPV2 AFDN MED12 PLXNA1 FXN ADNP TNN CST4 MACF1 ROBO1 | 1.12e-04 | 299 | 259 | 13 | GO:0060560 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | RELN MAP1B GH1 PTPRA TRPV2 AFDN EEF2K ADGRL2 PLXNA1 FLT1 CST7 RELA FXN ADNP TERT MACF1 ROBO1 SPEN AGRN SORL1 | 1.32e-04 | 625 | 259 | 20 | GO:0051960 |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 2.22e-04 | 238 | 259 | 11 | GO:0048639 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 2.23e-04 | 97 | 259 | 7 | GO:0032414 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 RELN ATP7A MAP1B MYCBP2 LHX9 CPNE6 DST SEMA5B CNTN5 TRPV2 ARC AFDN EEF2K PLXNA1 COL6A1 ANK3 LAMC1 FXN ADNP PREX2 CRB1 P2RX7 TNN IGHM MACF1 ROBO1 MAEL AGRN PHACTR1 | 2.36e-04 | 1194 | 259 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | response to magnesium ion | 2.50e-04 | 25 | 259 | 4 | GO:0032026 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | ABCA2 AMACR CEACAM6 PTDSS2 ACSS2 GGT1 SH3YL1 GH1 PIK3C2A PIK3R2 PGAP1 PIP5K1B PLA2G4F PLCG2 PIGO SLC27A5 HSD17B7 HACD3 LCAT P2RX7 GGTLC1 AACS EFR3B | 2.55e-04 | 813 | 259 | 23 | GO:0008610 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.58e-04 | 166 | 259 | 9 | GO:0014074 | |
| GeneOntologyBiologicalProcess | response to metal ion | ATP7A DAXX RYR3 CPNE6 DLG2 EEF2K PLCD1 PLCG2 ANK3 FXN LCAT TERT THBS1 P2RX7 ASPH | 2.59e-04 | 415 | 259 | 15 | GO:0010038 |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 2.67e-04 | 132 | 259 | 8 | GO:0006661 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | RELN PDGFRA TNFRSF14 EHD4 GH1 PLCG2 DYRK3 FLT1 ADNP YES1 IGHM CSPG4 AGRN | 2.69e-04 | 327 | 259 | 13 | GO:0018108 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | RELN PDGFRA TNFRSF14 EHD4 GH1 PLCG2 DYRK3 FLT1 ADNP YES1 IGHM CSPG4 AGRN | 2.85e-04 | 329 | 259 | 13 | GO:0018212 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | RELN MAP1B GH1 PTPRA TRPV2 AFDN EEF2K PLXNA1 FLT1 RELA FXN ADNP TERT MACF1 ROBO1 SPEN SORL1 | 2.96e-04 | 515 | 259 | 17 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | CYLD RELN MAP1B IL1RL2 GH1 PTPRA TRPV2 AFDN EEF2K PLXNA1 FLT1 RELA FXN ADNP ZBTB46 MACF1 ROBO1 PDE5A SPEN | 2.97e-04 | 614 | 259 | 19 | GO:0010720 |
| GeneOntologyBiologicalProcess | regulation of developmental growth | MAP1B MYCBP2 DAXX GH1 CPNE6 TRPV2 COL14A1 AFDN AKAP6 FOXS1 FXN ADNP MACF1 MAEL AGRN | 3.02e-04 | 421 | 259 | 15 | GO:0048638 |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 3.08e-04 | 170 | 259 | 9 | GO:0046488 | |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 RELN MAP1B MYCBP2 LHX9 DST SEMA5B CNTN5 TRPV2 PLXNA1 ANK3 LAMC1 FXN ADNP TNN MACF1 ROBO1 AGRN | 3.09e-04 | 566 | 259 | 18 | GO:0007409 |
| Domain | Cadherin_2 | PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 1.42e-09 | 65 | 260 | 11 | PF08266 |
| Domain | Cadherin_N | PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 1.42e-09 | 65 | 260 | 11 | IPR013164 |
| Domain | Cadherin_tail | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 1.51e-09 | 37 | 260 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 1.51e-09 | 37 | 260 | 9 | IPR031904 |
| Domain | Cadherin_CS | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 3.90e-09 | 109 | 260 | 13 | IPR020894 |
| Domain | Cadherin_C | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 5.11e-09 | 42 | 260 | 9 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 5.11e-09 | 42 | 260 | 9 | PF16492 |
| Domain | CADHERIN_1 | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 6.09e-09 | 113 | 260 | 13 | PS00232 |
| Domain | Cadherin | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 6.09e-09 | 113 | 260 | 13 | PF00028 |
| Domain | - | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 6.79e-09 | 114 | 260 | 13 | 2.60.40.60 |
| Domain | CADHERIN_2 | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 6.79e-09 | 114 | 260 | 13 | PS50268 |
| Domain | CA | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 7.56e-09 | 115 | 260 | 13 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 8.41e-09 | 116 | 260 | 13 | IPR015919 |
| Domain | Cadherin | DCHS2 PCDH12 DSG1 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDH7 PCDHGA8 | 1.04e-08 | 118 | 260 | 13 | IPR002126 |
| Domain | Laminin_G | 1.52e-04 | 58 | 260 | 6 | IPR001791 | |
| Domain | CoA-Trfase_III_dom | 1.93e-04 | 2 | 260 | 2 | IPR023606 | |
| Domain | CoA-Trfase_fam_III | 1.93e-04 | 2 | 260 | 2 | IPR003673 | |
| Domain | CoA_transf_3 | 1.93e-04 | 2 | 260 | 2 | PF02515 | |
| Domain | - | 1.93e-04 | 2 | 260 | 2 | 3.40.50.10540 | |
| Domain | MIR | 2.98e-04 | 10 | 260 | 3 | PF02815 | |
| Domain | MIR_motif | 2.98e-04 | 10 | 260 | 3 | IPR016093 | |
| Domain | MIR | 2.98e-04 | 10 | 260 | 3 | PS50919 | |
| Domain | MIR | 2.98e-04 | 10 | 260 | 3 | SM00472 | |
| Domain | IPT | 5.00e-04 | 27 | 260 | 4 | SM00429 | |
| Domain | CYSTATIN | 5.35e-04 | 12 | 260 | 3 | PS00287 | |
| Domain | RNA_pol_Rpb1_2 | 5.74e-04 | 3 | 260 | 2 | PF00623 | |
| Domain | RNA_pol_Rpb1_1 | 5.74e-04 | 3 | 260 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 5.74e-04 | 3 | 260 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 5.74e-04 | 3 | 260 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 5.74e-04 | 3 | 260 | 2 | PF05000 | |
| Domain | RNA_pol_Rpb1_4 | 5.74e-04 | 3 | 260 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 5.74e-04 | 3 | 260 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 5.74e-04 | 3 | 260 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 5.74e-04 | 3 | 260 | 2 | IPR007066 | |
| Domain | ATPASE_C | 5.74e-04 | 3 | 260 | 2 | PS00605 | |
| Domain | ATP_synth_F0_csu_DDCD_BS | 5.74e-04 | 3 | 260 | 2 | IPR020537 | |
| Domain | RNA_pol_asu | 5.74e-04 | 3 | 260 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 5.74e-04 | 3 | 260 | 2 | IPR006592 | |
| Domain | RPOLA_N | 5.74e-04 | 3 | 260 | 2 | SM00663 | |
| Domain | - | 5.74e-04 | 3 | 260 | 2 | 1.20.20.10 | |
| Domain | - | 5.77e-04 | 74 | 260 | 6 | 3.40.50.410 | |
| Domain | Ig_E-set | 6.30e-04 | 104 | 260 | 7 | IPR014756 | |
| Domain | TIG | 8.59e-04 | 31 | 260 | 4 | PF01833 | |
| Domain | Ig-like_fold | CHL1 PDGFRA MYCBP2 CEACAM6 NCAM2 IL1RL2 PIGR CNTN5 NECTIN4 COL14A1 PLXNA1 FLT1 COL20A1 RELA RELB PKHD1L1 CSF2RA TNN IGHM ROBO1 SORL1 | 9.25e-04 | 706 | 260 | 21 | IPR013783 |
| Domain | IPT | 9.71e-04 | 32 | 260 | 4 | IPR002909 | |
| Domain | VWFA | 9.94e-04 | 82 | 260 | 6 | PS50234 | |
| Domain | - | CHL1 PDGFRA MYCBP2 CEACAM6 NCAM2 IL1RL2 PIGR CNTN5 NECTIN4 COL14A1 PLXNA1 FLT1 COL20A1 RELA RELB PKHD1L1 CSF2RA TNN ROBO1 SORL1 | 1.03e-03 | 663 | 260 | 20 | 2.60.40.10 |
| Domain | VWA | 1.08e-03 | 56 | 260 | 5 | PF00092 | |
| Domain | VWA | 1.13e-03 | 84 | 260 | 6 | SM00327 | |
| Domain | ACAS_N | 1.14e-03 | 4 | 260 | 2 | PF16177 | |
| Domain | ATP_synth_F0_csu | 1.14e-03 | 4 | 260 | 2 | IPR000454 | |
| Domain | ACAS_N | 1.14e-03 | 4 | 260 | 2 | IPR032387 | |
| Domain | GlyclTrfase_39-like | 1.14e-03 | 4 | 260 | 2 | IPR027005 | |
| Domain | FN3 | 1.17e-03 | 185 | 260 | 9 | SM00060 | |
| Domain | ig | 1.41e-03 | 190 | 260 | 9 | PF00047 | |
| Domain | Immunoglobulin | 1.41e-03 | 190 | 260 | 9 | IPR013151 | |
| Domain | CY | 1.57e-03 | 17 | 260 | 3 | SM00043 | |
| Domain | EGF | 1.74e-03 | 235 | 260 | 10 | SM00181 | |
| Domain | Cystatin_dom | 1.86e-03 | 18 | 260 | 3 | IPR000010 | |
| Domain | Cystatin | 1.86e-03 | 18 | 260 | 3 | PF00031 | |
| Domain | IPT_NFkappaB | 1.88e-03 | 5 | 260 | 2 | IPR033926 | |
| Domain | ATP-synt_C | 1.88e-03 | 5 | 260 | 2 | PF00137 | |
| Domain | ATPase_proteolipid_c-like_dom | 1.88e-03 | 5 | 260 | 2 | IPR002379 | |
| Domain | RHD_CS | 1.88e-03 | 5 | 260 | 2 | IPR030492 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.30e-05 | 84 | 183 | 8 | M7098 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDH7 PCDHGA8 | 5.14e-13 | 74 | 269 | 12 | 10817752 |
| Pubmed | PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDH7 PCDHGA8 | 8.43e-13 | 77 | 269 | 12 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDH7 PCDHGA8 | 1.35e-12 | 80 | 269 | 12 | 10716726 |
| Pubmed | 9.35e-12 | 15 | 269 | 7 | 23515096 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDHGA8 | 9.62e-12 | 72 | 269 | 11 | 10380929 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDHGA8 | 1.27e-10 | 68 | 269 | 10 | 11230163 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | RELN PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHB18P PCDHGA12 | 5.64e-10 | 57 | 269 | 9 | 32633719 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.58e-09 | 28 | 269 | 7 | 15347688 | |
| Pubmed | CYLD ATP6V1B2 ATP7A MYCBP2 BCKDHA RPS25 ITPRID2 BCS1L ELAC2 EHD4 PNPT1 PIK3C2A PIK3R2 SDF2L1 COL14A1 EEF2K ASCC3 ADGRL2 CARS2 ZNHIT2 NENF SDF2 ITCH ANK3 HACD3 PMPCB LAMC1 YES1 IGF2R ASPH EFR3B PRKAR2A MACF1 ROBO1 PCDH7 | 5.37e-09 | 1487 | 269 | 35 | 33957083 | |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 6.89e-09 | 34 | 269 | 7 | 22884324 | |
| Pubmed | CYLD TET2 ATP6V1B2 DCHS2 RELN ABCA2 MYCBP2 USP25 NCAM2 RYR3 DMAP1 SH3YL1 SETDB1 PTPRA DST WIZ NAV3 FIP1L1 DLG2 AFDN HSD17B4 CARS2 AKAP6 ITCH ANK3 REV3L THBS1 MTA1 HEATR6 TJP1 MACF1 ROBO1 | 6.91e-09 | 1285 | 269 | 32 | 35914814 | |
| Pubmed | CYLD ATP7A KDM3B SPATA2 BIRC6 USP19 DST WIZ FIP1L1 AFDN EEF2K ADGRL2 PRRC2B ANK3 MUC16 RELA PKHD1L1 CRB1 IGF2R TJP1 ROBO1 SPEN PCDH7 RPL11 | 1.14e-08 | 777 | 269 | 24 | 35844135 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 ATP6V1B2 MAP1B MYCBP2 RPS25 ITPRID2 EHD4 DST FIP1L1 AFDN NOL7 ASCC3 HSD17B4 POLR1A TCF20 DSG1 HACD3 LAMC1 XRCC1 ADNP YES1 CDCA8 IGF2R TJP1 MACF1 SPEN RPL11 | 3.58e-08 | 1024 | 269 | 27 | 24711643 |
| Pubmed | 4.60e-08 | 44 | 269 | 7 | 19029045 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CYLD MAP1B MYCBP2 RC3H1 DAXX RPS25 GIT2 LARP4B WIZ SMG7 PIK3C2A FIP1L1 ASCC3 PRRC2B POLR1A DSG1 RBMS2 MTA1 TJP1 ANKRD17 MACF1 SPEN | 6.31e-08 | 724 | 269 | 22 | 36232890 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 MAP1B MYCBP2 RPS25 VPS16 BIRC6 ELAC2 EHD4 DST AP1G1 PIK3C2A FIP1L1 AFDN PLCG2 ASCC3 MED12 ITCH POLR1A TCF20 DSG1 HACD3 PMPCB OAS3 ADNP POLR3A ASPH CSTA ANKRD17 MACF1 AGRN RPL11 | 7.91e-08 | 1353 | 269 | 31 | 29467282 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CYLD MAP1B MYCBP2 USP25 KDM3B SPATA2 USP19 UBXN2B PIK3C2A KLHL23 UMPS ASCC3 SDF2 PRRC2B CCDC14 ITCH POLR1A DSG1 ADRM1 POLR3A FEM1B IGF2R TJP1 IGHM CSTA ANKRD17 | 9.43e-08 | 1005 | 269 | 26 | 19615732 |
| Pubmed | TET2 MYCBP2 BCORL1 CHEK1 BIRC6 SETDB1 DST WIZ ASCC3 MED12 COL6A1 TCF20 LAMC1 MORC4 ADNP ANKRD17 | 2.05e-07 | 418 | 269 | 16 | 34709266 | |
| Pubmed | ATP6V1B2 MYCBP2 BCKDHA ITPRID2 BIRC6 EHD4 PTPRA WIZ SMG7 POC5 HSD17B4 ADGRL2 PRRC2B CCDC14 ANK3 PMPCB RELA IDE XRCC1 CDCA8 IGF2R PPP3CC TJP1 EFR3B ROBO1 PCDH7 | 2.15e-07 | 1049 | 269 | 26 | 27880917 | |
| Pubmed | MTA2 MAP1B MYCBP2 BIRC6 PNPT1 LARP4B DST AFDN ASCC3 MED12 PRRC2B POLR1A TCF20 ADNP IGF2R TJP1 PREP ANKRD17 MACF1 SPEN | 2.26e-07 | 653 | 269 | 20 | 22586326 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MTA2 ABCA2 MAP1B MYCBP2 PTDSS2 ELAC2 USP19 DMAP1 CSGALNACT2 PGAP1 NENF PIGO PLXNA1 SDF2 COL4A4 COL6A1 HACD3 LAMC1 RELA THBS1 IGF2R CSPG4 ASPH ROBO1 CHSY3 PCDH7 AGRN SORL1 | 2.48e-07 | 1201 | 269 | 28 | 35696571 |
| Pubmed | CYLD TET2 RC3H1 BCORL1 RPS25 SPATA2 DMAP1 SETDB1 LARP4B LIN37 DST WIZ SMG7 SLX4IP FIP1L1 PRRC2B TCF20 ADRM1 HACD3 RELA RELB XRCC1 MLLT10 MORC4 FIGN ADNP MTA1 ANKRD17 SPEN PCDH7 SORL1 | 2.61e-07 | 1429 | 269 | 31 | 35140242 | |
| Pubmed | CYLD USP25 KDM3B SPATA2 USP19 SETDB1 DST UBXN2B SDF2L1 ASCC3 SDF2 CCDC14 ADRM1 RNF185 LAMC1 MACF1 AGRN | 2.61e-07 | 481 | 269 | 17 | 28190767 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | ATP6V1B2 ITPRID2 MAST2 CWC25 LHX9 EHD4 NAV3 PLCD1 CPLANE1 PRRC2B ITCH NMNAT1 RBMS2 IDE XRCC1 YES1 PREP IGHM ASPH ANKRD17 ASPRV1 | 3.27e-07 | 732 | 269 | 21 | 34732716 |
| Pubmed | CYLD KIF21B MYCBP2 WDR81 GIT2 DST WIZ ARC DLG2 AFDN PRRC2B ANKS1A ITCH TCF20 ANK3 ADNP IGF2R P2RX7 TJP1 PRKAR2A ANKRD17 MACF1 AGRN PHACTR1 | 5.85e-07 | 963 | 269 | 24 | 28671696 | |
| Pubmed | 6.53e-07 | 64 | 269 | 7 | 22261194 | ||
| Pubmed | 8.01e-07 | 23 | 269 | 5 | 9730685 | ||
| Pubmed | 8.01e-07 | 23 | 269 | 5 | 9278385 | ||
| Pubmed | 8.44e-07 | 130 | 269 | 9 | 12421765 | ||
| Pubmed | MTA2 ELAC2 DST AP1G1 HSD17B4 MED12 KPNA5 TCF20 RELA CDCA8 IGF2R PREP CSTA PRKAR2A MACF1 RPL11 | 1.02e-06 | 472 | 269 | 16 | 38943005 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ATP5MC2 PDGFRA BCKDHA RPS25 BCS1L GRPEL2 PNPT1 CSGALNACT2 AP1G1 FIP1L1 SDF2L1 HSD17B4 CARS2 PIGO PLXNA1 SDF2 COL6A1 HSD17B7 HACD3 HKDC1 LAMC1 OAS3 IGF2R TJP1 CSPG4 ASPH CST4 CSTA AGRN RPL11 | 1.11e-06 | 1451 | 269 | 30 | 30550785 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD TET2 MAP1B PDGFRA MYCBP2 KDM3B CHEK1 ITPRID2 MAST2 DST PIK3C2A DSTYK FIP1L1 AFDN ANKS1A ITCH TCF20 LAMC1 TJP1 ANKRD17 MACF1 PCDH7 | 1.17e-06 | 861 | 269 | 22 | 36931259 |
| Pubmed | CYLD MYCBP2 KDM3B GIT2 BIRC6 DST SMG7 WDR35 AKAP6 PRUNE2 MACF1 | 1.64e-06 | 225 | 269 | 11 | 12168954 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CYLD KDM3B WDR81 DAXX RPS25 SPATA2 SETDB1 LARP4B LIN37 SMG7 AP1G1 FIP1L1 KATNIP EEF2K POC5 ZNHIT2 MED12 ZC3H12A RBMS2 RELA RELB SNUPN TJP1 PRKAR2A | 2.16e-06 | 1038 | 269 | 24 | 26673895 |
| Pubmed | CHEK1 DMAP1 LARP4B WIZ RAD54B ASCC3 HSD17B4 MED12 HACD3 LAMC1 MORC4 MACF1 | 2.27e-06 | 281 | 269 | 12 | 24163370 | |
| Pubmed | MTA2 CYLD BCKDHA CHEK1 MAST2 DMAP1 SETDB1 LARP4B WIZ SMG7 PIK3R2 FIP1L1 ASCC3 ADGRL2 FHL3 PRRC2B ITCH KAT6A OAS3 REV3L TEP1 MTA1 ANKRD17 MACF1 SORL1 | 2.30e-06 | 1116 | 269 | 25 | 31753913 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MTA2 CHEK1 PTPRA SDF2L1 UMPS AFDN ASCC3 ADGRL2 FHL3 SDF2 PRRC2B KPNA5 ADRM1 HACD3 PMPCB LAMC1 IDE TJP1 PREP ASPH ANKRD17 ASPRV1 SORL1 | 2.51e-06 | 974 | 269 | 23 | 28675297 |
| Pubmed | GLS2 MAP1B RPS25 GRPEL2 EHD4 DST FAM186A DLG2 HSD17B4 PRRC2B PMPCB PCDHGB1 COL20A1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 HKDC1 SUGCT PCDHGA12 TJP1 TNN CSPG4 MACF1 POLQ SPEN PCDHGA8 | 2.92e-06 | 1442 | 269 | 29 | 35575683 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MTA2 MAP1B KDM3B RPS25 USP19 EHD4 SETDB1 AP1G1 PIK3C2A AFDN HSD17B4 PRRC2B ITCH DSG1 ADRM1 RBMS2 LAMC1 OAS3 RELA IDE ADNP YES1 HEATR6 IGF2R TJP1 CST4 PRKAR2A ANKRD17 | 3.10e-06 | 1367 | 269 | 28 | 32687490 |
| Pubmed | ATP6V1B2 MYCBP2 KDM3B RPS25 BIRC6 ELAC2 DMAP1 DST SDF2L1 CARS2 NENF PIGO PRRC2B ITCH ADRM1 LAMC1 RELB LARS2 YES1 IGF2R TJP1 PREP ASPH CSTA PRKAR2A MACF1 ROBO1 | 3.50e-06 | 1297 | 269 | 27 | 33545068 | |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | PDGFRA CHEK1 GH1 PIK3C2A UMPS ASCC3 HSD17B4 FLT1 XRCC1 REV3L TERT THBS1 IGF2R | 4.12e-06 | 351 | 269 | 13 | 20453000 |
| Pubmed | KIF21B TET2 DENND2A ABCA2 KDM3B DMAP1 DST SMG7 SEMA5B ADGRL2 ANKS1A AKAP6 ADNP EFR3B ANKRD17 MINDY1 | 4.39e-06 | 529 | 269 | 16 | 14621295 | |
| Pubmed | BCKDHA RPS25 BIRC6 PNPT1 LARP4B UMPS HSD17B4 CARS2 HSD17B7 POLR1A HACD3 ADNP LARS2 MTA1 PRKAR2A ANKRD17 | 4.95e-06 | 534 | 269 | 16 | 35032548 | |
| Pubmed | GLS2 GPD1L PIGR AP1G1 AFDN ADGRL2 ANK3 HKDC1 LAMC1 IDE PREP CST4 | 5.09e-06 | 304 | 269 | 12 | 32235678 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 5.85e-06 | 58 | 269 | 6 | 30377227 | |
| Pubmed | DAXX ITPRID2 SETDB1 DST PIK3R2 NAV3 CPLANE1 FHL3 CCDC14 TCF20 ANK3 RELA ANKRD17 MACF1 ROBO1 | 6.90e-06 | 486 | 269 | 15 | 20936779 | |
| Pubmed | MTA2 MAP1B MYCBP2 KDM3B DMAP1 WIZ SMG7 AFDN ASCC3 MED12 PRRC2B TCF20 ANK3 ADNP TJP1 SPEN | 7.00e-06 | 549 | 269 | 16 | 38280479 | |
| Pubmed | MAP1B BCORL1 MAST2 SMG7 UMPS POC5 FBXO34 PRRC2B CCDC14 COL4A4 FLT1 RBMS2 KAT6A LAMC1 XRCC1 CSTA PRKAR2A RPL11 | 8.36e-06 | 689 | 269 | 18 | 36543142 | |
| Pubmed | The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits. | 9.00e-06 | 6 | 269 | 3 | 32587091 | |
| Pubmed | 9.00e-06 | 6 | 269 | 3 | 10477764 | ||
| Pubmed | 9.76e-06 | 175 | 269 | 9 | 28071719 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.04e-05 | 134 | 269 | 8 | 25452129 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 1.09e-05 | 38 | 269 | 5 | 12482669 | |
| Pubmed | ATP7A MAP1B RPS25 DST AFDN ASCC3 ADGRL2 MED12 ANKS1A ANK3 HACD3 IGF2R EFR3B ANKRD17 MACF1 ROBO1 PCDH7 RPL11 | 1.20e-05 | 708 | 269 | 18 | 39231216 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | ATP5MC1 ATP5MC2 GLS2 AMACR SLC25A34 BCKDHA BCS1L ELAC2 GRPEL2 PNPT1 SLC25A35 SLC25A29 SARDH HSD17B4 CARS2 DHTKD1 PMPCB IDE FXN LARS2 SUGCT | 1.27e-05 | 926 | 269 | 21 | 20877624 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B DMAP1 LIN37 WIZ FIP1L1 ADGRL2 KPNA5 FOXS1 RELA RELB XRCC1 REV3L ADNP TTLL7 MTA1 CSTA ANKRD17 CHSY3 SPEN SORL1 | 1.37e-05 | 857 | 269 | 20 | 25609649 |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | PDGFRA BCKDHA RPS25 USP19 LARP4B DST PIK3C2A SDF2L1 UMPS FBXO34 HSD17B7 HACD3 RBMS2 ASPH | 1.38e-05 | 453 | 269 | 14 | 27113764 |
| Pubmed | MAP1B KDM3B MAST2 DST AP1G1 DSTYK RAD54B AFDN HSD17B4 PRRC2B POLR3A ASPH AACS ANKRD17 AGRN CWF19L1 SORL1 | 1.47e-05 | 650 | 269 | 17 | 38777146 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ATP7A WDR81 GIT2 CWC25 BIRC6 AFDN NOL7 NENF PIGO ADRM1 PMPCB LAMC1 FEM1B IGF2R EFR3B MACF1 ROBO1 AGRN | 1.48e-05 | 719 | 269 | 18 | 35337019 |
| Pubmed | Differential expression of individual gamma-protocadherins during mouse brain development. | 1.57e-05 | 7 | 269 | 3 | 15964765 | |
| Pubmed | Developmental SMAD6 loss leads to blood vessel hemorrhage and disrupted endothelial cell junctions. | 1.57e-05 | 7 | 269 | 3 | 30098998 | |
| Pubmed | MYCBP2 USP25 KDM3B SVEP1 SETDB1 DST AP1G1 AFDN PLCG2 ASCC3 ANK3 LAMC1 MORC4 YES1 CSPG4 MACF1 | 1.73e-05 | 591 | 269 | 16 | 15231748 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 ABCA2 MYCBP2 KDM3B MAST2 BIRC6 ELAC2 DST WIZ ARC MED12 PLXNA1 PRRC2B KAT6A RELB REV3L MLLT10 LARS2 TEP1 IGF2R CSPG4 SPEN AGRN | 1.91e-05 | 1105 | 269 | 23 | 35748872 |
| Pubmed | MYCBP2 BCORL1 ITPRID2 SMG7 MED12 PRRC2B CCDC14 TCF20 YES1 ANKRD17 | 2.12e-05 | 242 | 269 | 10 | 34011540 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MTA2 BCORL1 KDM3B DAXX DMAP1 WIZ RAD54B NOL7 TCF20 NMNAT1 KAT6A XRCC1 ADNP CDCA8 MTA1 SPEN | 2.44e-05 | 608 | 269 | 16 | 36089195 |
| Pubmed | 2.76e-05 | 23 | 269 | 4 | 20379146 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP6V1B2 MYCBP2 USP25 LARP4B ASCC3 HSD17B4 FHL3 NENF SDF2 PRRC2B KPNA5 COL6A1 PMPCB RBMS2 IDE HEATR6 IGF2R PRKAR2A | 2.76e-05 | 754 | 269 | 18 | 33060197 |
| Pubmed | 2.89e-05 | 251 | 269 | 10 | 29778605 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MTA2 MAP1B MYCBP2 BCKDHA RPS25 BIRC6 LARP4B NOL7 ASCC3 MED12 POLR1A NMNAT1 HACD3 KAT6A XRCC1 CDCA8 ASPH MACF1 | 3.01e-05 | 759 | 269 | 18 | 35915203 |
| Pubmed | 3.12e-05 | 156 | 269 | 8 | 29961565 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ITPRID2 KMT2E LARP4B PIK3R2 TECPR1 PRUNE2 ANK3 RELB MLLT10 ADNP YES1 MTA1 SPEN | 3.51e-05 | 430 | 269 | 13 | 35044719 |
| Pubmed | PDGFRA BIRC6 IL1RL2 CPNE6 DST CNTN5 DHTKD1 PRUNE2 KAT6A HKDC1 TEP1 | 3.67e-05 | 313 | 269 | 11 | 20800603 | |
| Pubmed | MYCBP2 GIT2 PCDH12 KMT2E MAST2 BIRC6 LARP4B DST PIK3C2A COL14A1 AKAP6 ITCH LAMC1 MACF1 | 3.80e-05 | 497 | 269 | 14 | 23414517 | |
| Pubmed | 3.90e-05 | 25 | 269 | 4 | 32266943 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 3.90e-05 | 25 | 269 | 4 | 17170699 | |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 3.91e-05 | 161 | 269 | 8 | 32572027 | |
| Pubmed | ATP6V1B2 ATP7A MYCBP2 CHEK1 ITPRID2 EHD4 LARP4B WIZ AP1G1 PIK3C2A SDF2L1 NENF PIGO PRRC2B LAMC1 YES1 IGF2R TJP1 ASPH PRKAR2A CWF19L1 | 4.32e-05 | 1007 | 269 | 21 | 34597346 | |
| Pubmed | SLC25A34 BCORL1 KDM3B GRPEL2 SDF2L1 NOL7 PRRC2B TCF20 MUC16 LAMC1 IDE REV3L MORC4 THBS1 ANKRD17 SPEN | 4.34e-05 | 638 | 269 | 16 | 31182584 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | MTA2 WIZ TCF20 DSG1 ADRM1 RBMS2 XRCC1 THBS1 MTA1 ANKRD17 TDP1 | 4.61e-05 | 321 | 269 | 11 | 32098917 |
| Pubmed | 5.34e-05 | 27 | 269 | 4 | 27178982 | ||
| Pubmed | 5.51e-05 | 169 | 269 | 8 | 31462741 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 20. | TSHZ2 VPS16 ACSS2 SPATA2 PTPRA FOXS1 ITCH ADRM1 COL20A1 CST7 ADNP ZBTB46 GGTLC1 CST4 | 5.81e-05 | 517 | 269 | 14 | 11780052 |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 26398300 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 36580757 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 35350380 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 11002341 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 8188306 | ||
| Pubmed | HSV-1 ICP27 represses NF-κB activity by regulating Daxx sumoylation. | 5.96e-05 | 2 | 269 | 2 | 28320502 | |
| Pubmed | De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor. | 5.96e-05 | 2 | 269 | 2 | 15265917 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 32125294 | ||
| Pubmed | FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction. | 5.96e-05 | 2 | 269 | 2 | 34304603 | |
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 25940087 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 12917431 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 17261495 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 14716817 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 8485160 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 18706197 | ||
| Pubmed | 5.96e-05 | 2 | 269 | 2 | 17299092 | ||
| Pubmed | Human telomerase contains evolutionarily conserved catalytic and structural subunits. | 5.96e-05 | 2 | 269 | 2 | 9389643 | |
| Pubmed | MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions. | 5.96e-05 | 2 | 269 | 2 | 34597441 | |
| Interaction | PCDHGA12 interactions | 8.22e-08 | 10 | 260 | 5 | int:PCDHGA12 | |
| Interaction | PCDHGA4 interactions | 2.19e-07 | 34 | 260 | 7 | int:PCDHGA4 | |
| Interaction | PCDHGA9 interactions | 3.60e-06 | 33 | 260 | 6 | int:PCDHGA9 | |
| Interaction | H2BC5 interactions | MAP1B CHEK1 DST TRPM8 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 IGF2R PCDHGA12 TNN PCDHGA8 CWF19L1 | 6.85e-06 | 331 | 260 | 16 | int:H2BC5 |
| Interaction | PCDHGA7 interactions | 1.48e-05 | 25 | 260 | 5 | int:PCDHGA7 | |
| Interaction | SYNE3 interactions | CYLD RC3H1 ITPRID2 SPATA2 DST SMG7 PIK3C2A COL14A1 NENF PIGO PRRC2B KPNA5 CCDC14 TCF20 LAMC1 IGF2R ASPH MACF1 | 2.02e-05 | 444 | 260 | 18 | int:SYNE3 |
| Interaction | PCDHGA8 interactions | 2.08e-05 | 5 | 260 | 3 | int:PCDHGA8 | |
| Cytoband | 5q31 | KDM3B PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDHGA8 | 4.83e-12 | 115 | 270 | 12 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | KDM3B PCDH12 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDHGA8 | 2.48e-07 | 298 | 270 | 12 | chr5q31 |
| Cytoband | 8p11 | 2.05e-04 | 4 | 270 | 2 | 8p11 | |
| Cytoband | 7q34 | 4.89e-04 | 167 | 270 | 6 | 7q34 | |
| Cytoband | 16q23 | 5.09e-04 | 6 | 270 | 2 | 16q23 | |
| GeneFamily | Clustered protocadherins | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHB18P PCDHGA12 PCDHGA8 | 1.20e-09 | 64 | 190 | 10 | 20 |
| GeneFamily | Collagens | 1.18e-04 | 46 | 190 | 5 | 490 | |
| GeneFamily | Fibronectin type III domain containing | 2.94e-04 | 160 | 190 | 8 | 555 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 9.78e-04 | 19 | 190 | 3 | 832 | |
| GeneFamily | Ankyrin repeat domain containing|NF-kappa B complex subunits | 1.08e-03 | 5 | 190 | 2 | 1254 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 2.23e-03 | 7 | 190 | 2 | 570 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 2.24e-03 | 87 | 190 | 5 | 372 | |
| GeneFamily | Acyl-CoA synthetase family | 2.49e-03 | 26 | 190 | 3 | 40 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.95e-03 | 8 | 190 | 2 | 939 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CHL1 CYLD KIF21B RELN FRMPD4 MAP1B MYCBP2 TSHZ2 KMT2E EHD4 GPD1L UBXN2B CNTN5 PGAP1 NAV3 DLG2 SARDH PLXNA1 PRRC2B AKAP6 ANK3 COL6A6 REV3L TTLL7 DACT3 ROBO1 CHSY3 PCDH7 CCDC144A | 3.16e-06 | 1106 | 266 | 29 | M39071 |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP | CHL1 NCAM2 GIT2 LARP4B SMG7 ADRM1 OAS3 RELB CDCA8 PPP3CC RPL11 | 5.65e-06 | 196 | 266 | 11 | M6293 |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | KIF21B BCORL1 GIT2 RTP4 PIK3C2A TRPV2 WDR35 NECTIN4 HSD17B7 RELB IGF2R | 6.53e-06 | 199 | 266 | 11 | M7498 |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | TET2 USP25 DAXX RTP4 PNPT1 UBXN2B NOL7 FBXO34 ITCH OAS3 AGRN | 6.85e-06 | 200 | 266 | 11 | M8559 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | MYCBP2 BIRC6 PIK3C2A ASCC3 CPLANE1 ANK3 LAMC1 IDE REV3L AGRN SORL1 | 2.00e-07 | 117 | 259 | 11 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | ARHGAP42 MAP1B PDGFRA MYCBP2 NCAM2 BIRC6 SETDB1 PIK3C2A CPLANE1 PRRC2B ANK3 LAMC1 REV3L TMTC4 AGRN | 7.36e-06 | 312 | 259 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CHL1 ARHGAP42 MAP1B PDGFRA MYCBP2 NCAM2 BIRC6 RYR3 SETDB1 DST PIK3C2A TRPV2 CPLANE1 PRRC2B ANK3 LAMC1 REV3L HEATR6 TMTC4 ROBO1 PDE5A ASPRV1 PCDH7 AGRN SORL1 | 1.97e-05 | 806 | 259 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | ARHGAP42 MYCBP2 BIRC6 PIK3C2A ASCC3 CPLANE1 COL4A4 ANK3 PMPCB LAMC1 IDE REV3L THBS1 PCDH7 AGRN | 6.23e-05 | 375 | 259 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ARHGAP42 MYCBP2 BIRC6 PIK3C2A ASCC3 ANK3 PMPCB LAMC1 IDE REV3L LARS2 THBS1 HEATR6 AGRN SORL1 | 7.02e-05 | 379 | 259 | 15 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | MAP1B MYCBP2 BIRC6 PIK3C2A COL14A1 ASCC3 CPLANE1 ANK3 LAMC1 IDE REV3L YES1 THBS1 HEATR6 AGRN | 8.37e-05 | 385 | 259 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | MYCBP2 BIRC6 PIK3C2A ASCC3 CPLANE1 ITCH ANK3 PMPCB LAMC1 IDE REV3L AGRN | 9.30e-05 | 261 | 259 | 12 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.31e-04 | 156 | 259 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.82e-04 | 163 | 259 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CHL1 MAP1B MYCBP2 NCAM2 BIRC6 RYR3 PIK3C2A NECTIN4 COL14A1 ASCC3 CPLANE1 ANK3 LAMC1 IDE REV3L YES1 THBS1 HEATR6 ASPH PDE5A CHSY3 AGRN SORL1 | 1.84e-04 | 818 | 259 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | MAP1B PDGFRA MYCBP2 SETDB1 PIK3C2A ASCC3 CPLANE1 ANK3 LAMC1 IDE REV3L YES1 HEATR6 AGRN | 1.89e-04 | 369 | 259 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 1.90e-04 | 164 | 259 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | PDGFRA TSHZ2 NCAM2 SVEP1 DST NAV3 DLG2 COL14A1 COL6A1 LAMC1 THBS1 KCNT2 SUGCT ROBO1 PCDH7 | 1.32e-12 | 197 | 269 | 15 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A PDGFRA NCAM2 SVEP1 DST PGAP1 NAV3 COL6A1 COL6A6 LAMC1 MACF1 ROBO1 PDE5A PCDH7 | 1.35e-11 | 192 | 269 | 14 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | DENND2A PDGFRA TSHZ2 NCAM2 SVEP1 DST NAV3 DLG2 COL14A1 COL6A1 COL6A6 LAMC1 THBS1 ROBO1 | 2.04e-11 | 198 | 269 | 14 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A PDGFRA NCAM2 SVEP1 DST PGAP1 NAV3 COL6A1 COL6A6 LAMC1 MACF1 ROBO1 PCDH7 | 1.73e-10 | 191 | 269 | 13 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | DENND2A BRINP3 MAP1B PDGFRA TSHZ2 DST NAV3 DLG2 COL14A1 COL6A1 KCNT2 SUGCT ROBO1 | 1.97e-10 | 193 | 269 | 13 | e6b75be08e33c1de079fb5c02f0b4468128b369c |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | DENND2A PDGFRA TSHZ2 NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 THBS1 SUGCT ROBO1 PCDH7 | 2.10e-10 | 194 | 269 | 13 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | PDGFRA TSHZ2 NCAM2 SVEP1 DST NAV3 DLG2 COL14A1 COL6A1 THBS1 SUGCT ROBO1 PCDH7 | 2.53e-10 | 197 | 269 | 13 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CHL1 PDGFRA SVEP1 DST COL14A1 COL6A1 COL6A6 LAMC1 REV3L PREX2 THBS1 MACF1 ROBO1 | 3.06e-10 | 200 | 269 | 13 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | PDGFRA MYCBP2 TSHZ2 SVEP1 DSTYK NAV3 DLG2 COL14A1 REV3L PREX2 PCDHGA12 ROBO1 | 1.43e-09 | 184 | 269 | 12 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | DENND2A BRINP3 PDGFRA TSHZ2 SVEP1 DST NAV3 ADGRL2 COL6A1 KCNT2 SUGCT ROBO1 | 1.72e-09 | 187 | 269 | 12 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | MAP1B DST DLG2 COL14A1 AKAP6 PRUNE2 TTLL7 THBS1 KCNT2 SUGCT PDE5A PCDH7 | 1.72e-09 | 187 | 269 | 12 | 464a0c3b92b778911b5f9cd73642e09e3472063a |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A PDGFRA NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 LAMC1 MACF1 ROBO1 PCDH7 | 2.93e-09 | 196 | 269 | 12 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ARHGAP42 DENND2A TSHZ2 NCAM2 SVEP1 DST COL14A1 COL6A1 COL6A6 THBS1 KCNT2 PCDH7 | 3.29e-09 | 198 | 269 | 12 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDGFRA TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 LAMC1 THBS1 ROBO1 | 3.29e-09 | 198 | 269 | 12 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A PDGFRA NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 LAMC1 MACF1 ROBO1 PCDH7 | 3.29e-09 | 198 | 269 | 12 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CHL1 DENND2A PDGFRA MYCBP2 SVEP1 DST COL14A1 COL6A1 COL6A6 REV3L THBS1 MACF1 | 3.48e-09 | 199 | 269 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | DENND2A TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 KCNT2 ROBO1 PCDH7 | 3.48e-09 | 199 | 269 | 12 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A MAP1B TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 KCNT2 PCDH7 | 3.69e-09 | 200 | 269 | 12 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | PDGFRA SVEP1 COL14A1 COL6A1 PREX2 THBS1 IGF2R DACT3 MACF1 ROBO1 PDE5A | 2.28e-08 | 189 | 269 | 11 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | DENND2A PDGFRA NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 THBS1 ROBO1 PCDH7 | 2.41e-08 | 190 | 269 | 11 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 ARHGAP42 DENND2A SVEP1 COL14A1 COL6A1 COL6A6 THBS1 DACT3 ROBO1 PCDH7 | 2.68e-08 | 192 | 269 | 11 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 ARHGAP42 DENND2A SVEP1 COL14A1 COL6A1 COL6A6 REV3L THBS1 ROBO1 PCDH7 | 2.68e-08 | 192 | 269 | 11 | df1545670370fb1010c567cd059c2783eab315f7 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCAM2 SVEP1 DST NAV3 COL6A1 LAMC1 PREX2 MACF1 ROBO1 PDE5A PCDH7 | 2.83e-08 | 193 | 269 | 11 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | DENND2A PDGFRA NCAM2 SVEP1 DST COL6A1 LAMC1 PREX2 MACF1 PDE5A PCDH7 | 2.83e-08 | 193 | 269 | 11 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | PDGFRA TSHZ2 NCAM2 SVEP1 COL14A1 COL6A1 COL6A6 PREX2 ROBO1 PDE5A PCDH7 | 2.98e-08 | 194 | 269 | 11 | 8c37bedb23285735ff3828db3889897fada8c95d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 ARHGAP42 DENND2A SVEP1 COL14A1 COL6A1 COL6A6 THBS1 DACT3 ROBO1 PCDH7 | 2.98e-08 | 194 | 269 | 11 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRA TSHZ2 CWC25 SVEP1 DST FIGN THBS1 KCNT2 ROBO1 PDE5A | 2.98e-08 | 194 | 269 | 11 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PDGFRA TSHZ2 CWC25 SVEP1 DST FIGN THBS1 KCNT2 ROBO1 PDE5A | 2.98e-08 | 194 | 269 | 11 | df82cce5ebeb73740b02cf816c6df82253cfd566 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | DENND2A PDGFRA NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 LAMC1 ROBO1 PDE5A | 3.14e-08 | 195 | 269 | 11 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN MAP1B MYCBP2 DST ASCC3 COL6A6 REV3L TTLL7 MACF1 PDE5A PHACTR1 | 3.14e-08 | 195 | 269 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | DENND2A TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 LAMC1 PCDH7 | 3.31e-08 | 196 | 269 | 11 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | ARHGAP42 DENND2A MAP1B KLHL23 FOXS1 COL6A1 PREX2 TTLL7 CSPG4 DACT3 PDE5A | 3.31e-08 | 196 | 269 | 11 | 754a3613340932563cd8424d775e18b93c3a1aaa |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A DCHS2 MAP1B TSHZ2 SVEP1 NAV3 PURG COL6A1 KCNT2 SUGCT ROBO1 | 3.49e-08 | 197 | 269 | 11 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | DENND2A PDGFRA TSHZ2 NCAM2 SVEP1 NAV3 COL6A1 COL6A6 LAMC1 ROBO1 PDE5A | 3.68e-08 | 198 | 269 | 11 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A MAP1B COL14A1 AKAP6 PRUNE2 VIPR2 COL6A1 TTLL7 CSPG4 DACT3 PCDH7 | 3.68e-08 | 198 | 269 | 11 | bd42c03e384e64f61b02618cf1a5440033bb04b2 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CHL1 SVEP1 DST COL14A1 COL6A1 COL6A6 LAMC1 PREX2 THBS1 MACF1 ROBO1 | 3.87e-08 | 199 | 269 | 11 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CHL1 DENND2A PDGFRA SVEP1 DST COL14A1 COL6A1 COL6A6 REV3L THBS1 MACF1 | 3.87e-08 | 199 | 269 | 11 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 THBS1 PCDH7 | 4.07e-08 | 200 | 269 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | CHL1 PDGFRA MYCBP2 SVEP1 DST COL14A1 COL6A1 COL6A6 REV3L THBS1 MACF1 | 4.07e-08 | 200 | 269 | 11 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 THBS1 ROBO1 PDE5A PCDH7 | 4.07e-08 | 200 | 269 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ITPRID2 PCDH12 BIRC6 DST PIK3C2A AFDN ADGRL2 FLT1 PREX2 TJP1 MACF1 | 4.07e-08 | 200 | 269 | 11 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 THBS1 ROBO1 | 4.07e-08 | 200 | 269 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A PDGFRA NCAM2 SVEP1 NAV3 COL14A1 COL6A1 COL6A6 LAMC1 PREX2 KCNT2 | 4.07e-08 | 200 | 269 | 11 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A TSHZ2 NCAM2 SVEP1 DST NAV3 COL14A1 COL6A1 COL6A6 THBS1 PCDH7 | 4.07e-08 | 200 | 269 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | MAP1B RYR3 COL14A1 AKAP6 PRUNE2 VIPR2 COL6A1 DACT3 PDE5A PCDH7 | 1.07e-07 | 173 | 269 | 10 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 ATP7A PDGFRA SEMA5B KATNIP TP53I11 LAMC1 ZBTB46 CSPG4 DACT3 | 1.19e-07 | 175 | 269 | 10 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | CEACAM6 ZC3H12B GGT1 DST PLXNA1 COL4A4 TTLL7 KCNT2 GGTLC1 AGRN | 1.55e-07 | 180 | 269 | 10 | e1964002681f80d8d62406b6ee52a01e1829ccf2 |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-07 | 182 | 269 | 10 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 MAP1B PDGFRA TSHZ2 SVEP1 COL14A1 VIPR2 FIGN THBS1 DACT3 | 1.71e-07 | 182 | 269 | 10 | 44764676ed3f51ba171ce63f669390392fa50a43 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 MAP1B PDGFRA TSHZ2 SVEP1 COL14A1 VIPR2 FIGN THBS1 DACT3 | 1.71e-07 | 182 | 269 | 10 | d82f59a3f930a840dde27dc6ab024f227a26d446 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | DENND2A MAP1B TSHZ2 SVEP1 COL6A1 FLT1 LAMC1 PREX2 KCNT2 ROBO1 | 1.71e-07 | 182 | 269 | 10 | fbd5e332df73bf7141c822fa67b76367dc962017 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP42 DENND2A FOXS1 VIPR2 COL6A1 COL6A6 KCNT2 CSPG4 DACT3 PDE5A | 1.90e-07 | 184 | 269 | 10 | 102b6f621a5b551e622f97b12d787c080b052a72 |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DENND2A PDGFRA FIP1L1 AFDN VIPR2 COL20A1 PCDHGA9 REV3L PCDHGA12 AGRN | 2.10e-07 | 186 | 269 | 10 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | CEACAM6 ITPRID2 GGT1 DST PLXNA1 COL4A4 TTLL7 KCNT2 GGTLC1 AGRN | 2.20e-07 | 187 | 269 | 10 | 3a032432f780525f4f4c2a358897d9989b1ecae7 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ARHGAP42 TSHZ2 SVEP1 PGAP1 COL14A1 COL6A1 SUGCT ROBO1 PDE5A PCDH7 | 2.20e-07 | 187 | 269 | 10 | a9316e2818217ec5feae9cf8816f7249803caee6 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | DENND2A PDGFRA NCAM2 SVEP1 DST PGAP1 NAV3 COL6A6 MACF1 ROBO1 | 2.20e-07 | 187 | 269 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | CHL1 ARHGAP42 BRINP3 PDGFRA TSHZ2 NCAM2 COL14A1 PREX2 PDE5A PCDH7 | 2.55e-07 | 190 | 269 | 10 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B NAV3 COL14A1 AKAP6 COL6A1 TTLL7 THBS1 KCNT2 DACT3 PCDH7 | 2.55e-07 | 190 | 269 | 10 | 562ee3b025c29edf07b8b344323edb49d82f1c7e |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ARHGAP42 DST PIP5K1B AFDN COL4A4 TTLL7 KCNT2 TJP1 GGTLC1 PHACTR1 | 2.55e-07 | 190 | 269 | 10 | 30b50d183d7649146eb1e79b47ba897355f1998a |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-07 | 190 | 269 | 10 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B NAV3 COL14A1 AKAP6 COL6A1 TTLL7 THBS1 KCNT2 DACT3 PCDH7 | 2.55e-07 | 190 | 269 | 10 | f5fb989afabb49d64d91324570cd8c80a4b9e67d |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 PDGFRA TSHZ2 SVEP1 COL14A1 COL4A4 FIGN KCNT2 ROBO1 CHSY3 | 2.68e-07 | 191 | 269 | 10 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 DENND2A FRMPD4 SVEP1 COL14A1 COL6A1 COL6A6 THBS1 ROBO1 PCDH7 | 2.68e-07 | 191 | 269 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | DENND2A TSHZ2 NCAM2 SVEP1 COL4A4 COL6A1 LAMC1 REV3L ROBO1 CATSPERB | 2.68e-07 | 191 | 269 | 10 | 70c067c54084bfb02c29bab085f4defd477194fb |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 PDGFRA TSHZ2 SVEP1 COL14A1 COL4A4 FIGN KCNT2 ROBO1 CHSY3 | 2.68e-07 | 191 | 269 | 10 | 8f6d592edc32fdb901af30501d4360512334e8c2 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | BRINP3 TSHZ2 NCAM2 SVEP1 NAV3 COL14A1 COL6A1 COL6A6 KCNT2 PCDH7 | 2.81e-07 | 192 | 269 | 10 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | ARHGAP42 BRINP3 PDGFRA NCAM2 EHD4 ARC COL20A1 P2RX7 CSPG4 PCDH7 | 2.81e-07 | 192 | 269 | 10 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 DENND2A FRMPD4 SVEP1 COL14A1 COL6A1 COL6A6 THBS1 ROBO1 PCDH7 | 2.81e-07 | 192 | 269 | 10 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | DENND2A TSHZ2 NCAM2 SVEP1 COL4A4 COL6A1 LAMC1 KCNT2 ROBO1 CATSPERB | 2.81e-07 | 192 | 269 | 10 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | ARHGAP42 BRINP3 PDGFRA NCAM2 EHD4 ARC COL20A1 P2RX7 CSPG4 PCDH7 | 2.81e-07 | 192 | 269 | 10 | e6d115143ced6a0d9fe7c98acd3f730bac83f66b |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | DENND2A BRINP3 TSHZ2 SVEP1 NAV3 COL14A1 COL6A1 COL6A6 KCNT2 PCDH7 | 2.81e-07 | 192 | 269 | 10 | a769158c49d2b208c4224d85e7ae68c85cc372ed |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 DENND2A FRMPD4 SVEP1 DLG2 COL14A1 COL6A1 COL6A6 ROBO1 PCDH7 | 2.95e-07 | 193 | 269 | 10 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | TSHZ2 NCAM2 SVEP1 PGAP1 COL4A4 COL6A1 LAMC1 KCNT2 ROBO1 CATSPERB | 2.95e-07 | 193 | 269 | 10 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | DENND2A TSHZ2 NCAM2 SVEP1 DST COL6A1 COL6A6 LAMC1 ROBO1 PCDH7 | 2.95e-07 | 193 | 269 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | BRINP3 TSHZ2 NCAM2 SVEP1 NAV3 COL14A1 COL6A1 COL6A6 PDE5A PCDH7 | 3.09e-07 | 194 | 269 | 10 | 439d3f17c1f4736122b330e98add9292c7036a8e |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PIP5K1B AKAP6 VIPR2 TTLL7 KCNT2 CSPG4 DACT3 PDE5A PCDH7 | 3.09e-07 | 194 | 269 | 10 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 DENND2A FRMPD4 SVEP1 DLG2 COL14A1 COL6A6 THBS1 ROBO1 PCDH7 | 3.09e-07 | 194 | 269 | 10 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP1B PIP5K1B AKAP6 VIPR2 TTLL7 KCNT2 CSPG4 DACT3 PDE5A PCDH7 | 3.09e-07 | 194 | 269 | 10 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | ARHGAP42 DENND2A MAP1B KLHL23 AKAP6 FOXS1 PRUNE2 TTLL7 CSPG4 PDE5A | 3.09e-07 | 194 | 269 | 10 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CHL1 DENND2A FRMPD4 SVEP1 DLG2 COL14A1 COL6A1 COL6A6 ROBO1 PCDH7 | 3.09e-07 | 194 | 269 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | PDGFRA TSHZ2 NCAM2 RPS25 CNTN5 COL14A1 ROBO1 PDE5A PCDH7 RPL11 | 3.09e-07 | 194 | 269 | 10 | 85e00861c5068a27d0cf0ae677f420c8245baa9a |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | BRINP3 SVEP1 NAV3 COL14A1 COL6A1 COL6A6 FIGN PREX2 PDE5A PCDH7 | 3.24e-07 | 195 | 269 | 10 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.24e-07 | 195 | 269 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | TSHZ2 NCAM2 SVEP1 COL4A4 COL6A1 LAMC1 REV3L KCNT2 ROBO1 CATSPERB | 3.24e-07 | 195 | 269 | 10 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | ARHGAP42 MAP1B TSHZ2 SVEP1 COL4A4 REV3L FIGN THBS1 KCNT2 ROBO1 | 3.24e-07 | 195 | 269 | 10 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN MAP1B MYCBP2 DST ASCC3 COL6A6 REV3L TTLL7 MACF1 PHACTR1 | 3.24e-07 | 195 | 269 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | DENND2A NCAM2 SVEP1 DST NAV3 COL6A1 COL6A6 LAMC1 ROBO1 PDE5A | 3.24e-07 | 195 | 269 | 10 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | CEACAM6 GGT1 DST PLXNA1 COL4A4 TTLL7 KCNT2 GGTLC1 EFR3B AGRN | 3.24e-07 | 195 | 269 | 10 | 792d6a49b0a875a00569071183d195287a9925c5 |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | MAP1B TSHZ2 NCAM2 NAV3 COL14A1 COL6A1 COL6A6 KCNT2 ROBO1 PCDH7 | 3.40e-07 | 196 | 269 | 10 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CHL1 PDGFRA SVEP1 COL14A1 ADGRL2 COL6A1 LAMC1 REV3L FIGN PCDH7 | 3.40e-07 | 196 | 269 | 10 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | CEACAM6 GGT1 DST PLXNA1 COL4A4 TTLL7 KCNT2 GGTLC1 EFR3B AGRN | 3.40e-07 | 196 | 269 | 10 | 6c99d29162848161c1f166a032320f87a5d5a631 |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | TSHZ2 NCAM2 NAV3 DLG2 COL14A1 COL6A1 COL6A6 LAMC1 KCNT2 ROBO1 | 3.40e-07 | 196 | 269 | 10 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | ATP5MC2 TSHZ2 RPS25 SVEP1 COL14A1 COL6A1 SUGCT ROBO1 PDE5A PCDH7 | 3.40e-07 | 196 | 269 | 10 | 22538376a95fe3afe8639a216a5497087aa94110 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-07 | 197 | 269 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A NCAM2 SVEP1 NAV3 COL14A1 PRUNE2 COL6A1 COL6A6 PREX2 SUGCT | 3.56e-07 | 197 | 269 | 10 | 0dd71e399f253787fa546a7e90c5373180b89ffd |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP42 CEACAM6 DST COL4A4 TTLL7 KCNT2 TJP1 EFR3B AGRN PHACTR1 | 3.56e-07 | 197 | 269 | 10 | 8d5097898dd01cedb04cb694cb480c931e08462c |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | TSHZ2 NCAM2 CSGALNACT2 DLG2 ANK3 COL6A6 SUGCT MACF1 ROBO1 PCDH7 | 3.56e-07 | 197 | 269 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ARHGAP42 MAP1B PDGFRA TSHZ2 KLHL23 COL14A1 COL6A1 THBS1 ROBO1 PDE5A | 3.73e-07 | 198 | 269 | 10 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | DENND2A MAP1B PDGFRA SVEP1 COL14A1 COL4A4 COL6A1 ANK3 FIGN CHSY3 | 3.73e-07 | 198 | 269 | 10 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | CHL1 DENND2A PDGFRA MYCBP2 SVEP1 COL14A1 COL6A1 COL6A6 REV3L THBS1 | 3.91e-07 | 199 | 269 | 10 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | MTA2 DENND2A GLS2 MAST2 SMG7 HOXD4 PIK3R2 RAD54B SDF2 RELB MLLT10 THBS1 MTA1 | 5.31e-07 | 197 | 263 | 13 | 4658_DN |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | MTA2 DENND2A MAP1B PDGFRA AKAP6 FLT1 DSG1 KAT6A POU3F4 ASPH SPEN MINDY1 | 3.54e-06 | 198 | 263 | 12 | 4343_UP |
| Drug | CID9959010 | 5.32e-06 | 39 | 263 | 6 | CID009959010 | |
| Drug | mangiferin | 1.30e-05 | 27 | 263 | 5 | CID005281647 | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | CEACAM6 PTPRA SMG7 ARC VIPR2 COL6A1 ZC3H12A TP53I11 MTA1 SPEN CWF19L1 | 1.69e-05 | 194 | 263 | 11 | 5362_UP |
| Drug | NSC750927 | CEACAM6 CHEK1 LARP4B UMPS SLC25A29 ANK3 RELA RELB XRCC1 REV3L TERT POLQ | 1.77e-05 | 232 | 263 | 12 | CID000003461 |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | AMACR GIT2 DSTYK COL14A1 C8A CPLANE1 COL4A4 COL6A1 MTA1 PRKAR2A MINDY1 | 1.78e-05 | 195 | 263 | 11 | 5468_UP |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | RELN ABCA2 MAP1B MAST2 PIGR ZNHIT2 PLXNA1 ANK3 PREX2 THBS1 MANSC1 | 1.78e-05 | 195 | 263 | 11 | 3124_UP |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | GLS2 BCORL1 MAST2 USP19 WIZ HOXD4 PIGO TEP1 THBS1 MACF1 CWF19L1 | 1.96e-05 | 197 | 263 | 11 | 4532_DN |
| Drug | 3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | MTA2 ABCA2 CEACAM6 GIT2 PGAP1 ZNHIT2 MED12 COL6A1 TP53I11 THBS1 PRKAR2A | 1.96e-05 | 197 | 263 | 11 | 7361_DN |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; HL60; HT_HG-U133A | CHL1 RELN AMACR PCDH12 MAST2 PIGR NENF PURG PRUNE2 MTHFSD AGRN | 1.96e-05 | 197 | 263 | 11 | 3094_UP |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A | MTA2 CYLD CEACAM6 PTDSS2 GIT2 MAST2 CWC25 MLLT10 MANSC1 ASPH MINDY1 | 1.96e-05 | 197 | 263 | 11 | 1501_UP |
| Drug | Scopoletin [92-61-5]; Up 200; 20.8uM; HL60; HT_HG-U133A | RELN CEACAM6 WIZ COL14A1 C8A ZNHIT2 PRUNE2 COL6A1 ANK3 TTLL7 TJP1 | 2.25e-05 | 200 | 263 | 11 | 3131_UP |
| Drug | pyrophosphate | PTDSS2 ACSS2 PIK3C2A PIK3R2 UMPS AFDN PLCD1 PLCG2 CARS2 DHTKD1 SLC27A5 COL6A1 POLR1A NMNAT1 XRCC1 REV3L LARS2 TERT POLR3A AACS POLQ | 2.64e-05 | 654 | 263 | 21 | CID000001023 |
| Disease | Sarcosine measurement | CNTN5 SARDH PCDHGB1 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA8 | 1.84e-13 | 23 | 257 | 9 | EFO_0021668 |
| Disease | mental development measurement | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA8 | 2.83e-11 | 25 | 257 | 8 | EFO_0008230 |
| Disease | childhood trauma measurement, alcohol consumption measurement | PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 PCDHGA12 PCDHGA8 | 1.17e-08 | 71 | 257 | 9 | EFO_0007878, EFO_0007979 |
| Disease | Fetal Alcohol Syndrome | 1.22e-05 | 17 | 257 | 4 | C0015923 | |
| Disease | Malignant neoplasm of prostate | TET2 AMACR ELAC2 GGT1 SETDB1 PIK3R2 SDF2L1 UMPS MED12 KAT6A LAMC1 XRCC1 TERT IGF2R ROBO1 SPEN RPL11 | 3.26e-05 | 616 | 257 | 17 | C0376358 |
| Disease | Prostatic Neoplasms | TET2 AMACR ELAC2 GGT1 SETDB1 PIK3R2 SDF2L1 UMPS MED12 KAT6A LAMC1 XRCC1 TERT IGF2R ROBO1 SPEN RPL11 | 3.26e-05 | 616 | 257 | 17 | C0033578 |
| Disease | Schizophrenia | CHL1 RELN AMACR HTR3E CHEK1 KCNH6 SETDB1 PTPRA ARC DLG2 MED12 VIPR2 ANK3 RELA IDE XRCC1 ADNP LARS2 THBS1 PPP3CC CSF2RA | 3.50e-05 | 883 | 257 | 21 | C0036341 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.43e-05 | 45 | 257 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | diet measurement | BRINP3 HTR3E KDM3B DMAP1 PTPRA DST UBXN2B DSTYK CNTN5 DLG2 PLCG2 ADGRL2 PURG ITCH TCF20 ANK3 MLLT10 LARS2 ZBTB46 EFR3B ROBO1 PCDH7 SORL1 | 5.18e-05 | 1049 | 257 | 23 | EFO_0008111 |
| Disease | Chronic eosinophilic leukemia | 7.56e-05 | 2 | 257 | 2 | C0346421 | |
| Disease | Eosinophilic leukemia | 7.56e-05 | 2 | 257 | 2 | C0206142 | |
| Disease | Loeffler's Endocarditis | 7.56e-05 | 2 | 257 | 2 | C0206143 | |
| Disease | Idiopathic Hypereosinophilic Syndrome | 7.56e-05 | 2 | 257 | 2 | C0206141 | |
| Disease | hemopexin measurement | 1.02e-04 | 11 | 257 | 3 | EFO_0008149 | |
| Disease | brain measurement, neuroimaging measurement | KIF21B DCHS2 ELAC2 DSTYK NAV3 DLG2 ANKS1A ANK3 LAMC1 MLLT10 THBS1 MACF1 ROBO1 CATSPERB MAEL | 1.08e-04 | 550 | 257 | 15 | EFO_0004346, EFO_0004464 |
| Disease | Intellectual Disability | CHL1 FRMPD4 MAP1B KDM3B PCDH12 KMT2E PNPT1 UMPS ASCC3 AKAP6 TCF20 MACF1 PHACTR1 | 1.67e-04 | 447 | 257 | 13 | C3714756 |
| Disease | Fetal Alcohol Spectrum Disorders | 1.75e-04 | 13 | 257 | 3 | C2985290 | |
| Disease | melanoma (is_marker_for) | 1.89e-04 | 33 | 257 | 4 | DOID:1909 (is_marker_for) | |
| Disease | breast carcinoma, hormone replacement therapy | 2.25e-04 | 3 | 257 | 2 | EFO_0000305, EFO_0003961 | |
| Disease | mitochondrial complex V (ATP synthase) deficiency (implicated_via_orthology) | 2.25e-04 | 3 | 257 | 2 | DOID:0111143 (implicated_via_orthology) | |
| Disease | Headache | 2.42e-04 | 64 | 257 | 5 | HP_0002315 | |
| Disease | Familial Alzheimer Disease (FAD) | 2.48e-04 | 100 | 257 | 6 | C0276496 | |
| Disease | mean platelet volume | TET2 GLS2 BCORL1 SVEP1 DSTYK UMPS PLCG2 FBXO34 ANKS1A COL6A6 PCDHGB1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA4 PCDHGA3 PCDHGA2 TERT PCDHGA12 CATSPERB PCDHGA8 | 2.59e-04 | 1020 | 257 | 21 | EFO_0004584 |
| Disease | Alzheimer's Disease | 2.62e-04 | 101 | 257 | 6 | C0002395 | |
| Disease | migraine without aura, susceptibility to, 4 | 3.36e-04 | 16 | 257 | 3 | MONDO_0011847 | |
| Disease | coronary artery disease, factor VII measurement | 4.35e-04 | 111 | 257 | 6 | EFO_0001645, EFO_0004619 | |
| Disease | Hypereosinophilic syndrome | 4.48e-04 | 4 | 257 | 2 | C1540912 | |
| Disease | cation-independent mannose-6-phosphate receptor measurement | 4.48e-04 | 4 | 257 | 2 | EFO_0008075 | |
| Disease | primary biliary cholangitis (implicated_via_orthology) | 4.48e-04 | 4 | 257 | 2 | DOID:12236 (implicated_via_orthology) | |
| Disease | Adrenocortical carcinoma | 4.84e-04 | 18 | 257 | 3 | C0206686 | |
| Disease | waist-hip ratio | TET2 GLS2 MYCBP2 TSHZ2 BIRC6 RTP4 DSTYK CNTN5 NAV3 WDR35 DLG2 COL14A1 POC5 PURG PRUNE2 ANK3 RNF185 MLLT10 FIGN KCNT2 EFR3B ROBO1 PDE5A | 4.92e-04 | 1226 | 257 | 23 | EFO_0004343 |
| Disease | Malignant neoplasm of breast | BCORL1 CHEK1 HOXA4 SEMA5B UMPS ZNHIT2 MED12 PURG AKAP6 KPNA5 FLT1 RELA TERT THBS1 KCNT2 TMTC4 CST4 MACF1 ROBO1 SPEN SORL1 | 5.10e-04 | 1074 | 257 | 21 | C0006142 |
| Disease | schizophrenia (is_marker_for) | 5.80e-04 | 44 | 257 | 4 | DOID:5419 (is_marker_for) | |
| Disease | Perrault syndrome (is_implicated_in) | 7.43e-04 | 5 | 257 | 2 | DOID:0050857 (is_implicated_in) | |
| Disease | bacterial infectious disease (implicated_via_orthology) | 7.43e-04 | 5 | 257 | 2 | DOID:104 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | TET2 DCHS2 RELN GLS2 MYCBP2 MAST2 ELAC2 SVEP1 CSGALNACT2 DSTYK NAV3 IMMP1L ADGRL2 ANKS1A ITCH ANK3 LAMC1 THBS1 TJP1 PRKAR2A MACF1 ROBO1 MAEL PCDH7 | 7.50e-04 | 1345 | 257 | 24 | EFO_0010736 |
| Disease | Antimigraine preparation use measurement | 7.73e-04 | 21 | 257 | 3 | EFO_0009939 | |
| Disease | cystatin C measurement | LARP4B PIK3C2A SLX4IP PIP5K1B SNUPN CRB1 GGTLC1 CSPG4 CST4 PDE5A MINDY1 | 8.65e-04 | 402 | 257 | 11 | EFO_0004617 |
| Disease | cholangiocarcinoma (is_implicated_in) | 8.90e-04 | 22 | 257 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 1.11e-03 | 6 | 257 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | leiomyosarcoma (is_marker_for) | 1.11e-03 | 6 | 257 | 2 | DOID:1967 (is_marker_for) | |
| Disease | Perrault syndrome | 1.11e-03 | 6 | 257 | 2 | cv:C0685838 | |
| Disease | Global developmental delay | 1.12e-03 | 133 | 257 | 6 | C0557874 | |
| Disease | risk-taking behaviour | TET2 RELN TSHZ2 KMT2E BIRC6 LHX9 AP1G1 DSTYK ASCC3 TCF20 REV3L FIGN PPP3CC KCNT2 PCDH7 SORL1 | 1.17e-03 | 764 | 257 | 16 | EFO_0008579 |
| Disease | neuroimaging measurement | KIF21B DCHS2 RELN MAP1B ELAC2 DSTYK NAV3 UMPS DLG2 ANKS1A ITCH ANK3 LAMC1 REV3L MLLT10 THBS1 MACF1 ROBO1 MAEL PCDH7 | 1.18e-03 | 1069 | 257 | 20 | EFO_0004346 |
| Disease | Gonadal dysgenesis XX type deafness | 1.54e-03 | 7 | 257 | 2 | C0685838 | |
| Disease | Common Migraine | 1.54e-03 | 7 | 257 | 2 | C0338480 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.54e-03 | 7 | 257 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | birth measurement, spontaneous preterm birth | 1.54e-03 | 7 | 257 | 2 | EFO_0006917, EFO_0006921 | |
| Disease | health study participation | 1.67e-03 | 195 | 257 | 7 | EFO_0010130 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.76e-03 | 59 | 257 | 4 | EFO_0009658, GO_0009410 | |
| Disease | Acute Confusional Senile Dementia | 1.77e-03 | 99 | 257 | 5 | C0546126 | |
| Disease | Alzheimer Disease, Late Onset | 1.77e-03 | 99 | 257 | 5 | C0494463 | |
| Disease | Alzheimer's Disease, Focal Onset | 1.77e-03 | 99 | 257 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 1.77e-03 | 99 | 257 | 5 | C0750901 | |
| Disease | Presenile dementia | 1.77e-03 | 99 | 257 | 5 | C0011265 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.82e-03 | 28 | 257 | 3 | DOID:8634 (is_marker_for) | |
| Disease | respiratory failure, COVID-19 | 2.02e-03 | 29 | 257 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | complement factor H-related protein 2 measurement | 2.02e-03 | 29 | 257 | 3 | EFO_0600055 | |
| Disease | Congenital Amaurosis of Retinal Origin | 2.04e-03 | 8 | 257 | 2 | C3540662 | |
| Disease | alcohol dependence (biomarker_via_orthology) | 2.04e-03 | 8 | 257 | 2 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Leydig cell tumor (is_marker_for) | 2.04e-03 | 8 | 257 | 2 | DOID:2696 (is_marker_for) | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 2.24e-03 | 63 | 257 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.37e-03 | 154 | 257 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | cancer (implicated_via_orthology) | 2.54e-03 | 268 | 257 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Acute Confusional Migraine | 2.61e-03 | 9 | 257 | 2 | C0521664 | |
| Disease | Status Migrainosus | 2.61e-03 | 9 | 257 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 2.61e-03 | 9 | 257 | 2 | C0270858 | |
| Disease | Sick Headaches | 2.61e-03 | 9 | 257 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 2.61e-03 | 9 | 257 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 2.61e-03 | 9 | 257 | 2 | C0018984 | |
| Disease | breast carcinoma (is_marker_for) | 2.65e-03 | 66 | 257 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Uterine leiomyoma, breast carcinoma | 2.69e-03 | 32 | 257 | 3 | EFO_0000305, HP_0000131 | |
| Disease | Nonorganic psychosis | 3.12e-03 | 69 | 257 | 4 | C0349204 | |
| Disease | factor VIII measurement, coronary artery disease | 3.15e-03 | 113 | 257 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | acute lymphoblastic leukemia (is_marker_for) | 3.20e-03 | 34 | 257 | 3 | DOID:9952 (is_marker_for) | |
| Disease | urate measurement, bone density | TSHZ2 RC3H1 PEBP4 LARP4B DLG2 PRRC2B AKAP6 VIPR2 PMPCB HEATR6 MANSC1 PRKAR2A ROBO1 | 3.25e-03 | 619 | 257 | 13 | EFO_0003923, EFO_0004531 |
| Disease | prostate adenocarcinoma (is_marker_for) | 3.25e-03 | 10 | 257 | 2 | DOID:2526 (is_marker_for) | |
| Disease | age at onset, multiple sclerosis | 3.25e-03 | 10 | 257 | 2 | EFO_0004847, MONDO_0005301 | |
| Disease | factor XI measurement, coronary artery disease | 3.40e-03 | 115 | 257 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 3.46e-03 | 71 | 257 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | neuroimaging measurement, brain volume measurement | 3.76e-03 | 286 | 257 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 3.80e-03 | 118 | 257 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | glutamine measurement, amino acid measurement | 3.95e-03 | 11 | 257 | 2 | EFO_0005134, EFO_0009768 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 3.95e-03 | 11 | 257 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | ovary epithelial cancer (is_implicated_in) | 3.95e-03 | 11 | 257 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | cysteine-glutathione disulfide measurement | 3.95e-03 | 11 | 257 | 2 | EFO_0021001 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 4.01e-03 | 74 | 257 | 4 | EFO_0007869, EFO_0007878 | |
| Disease | Combined oxidative phosphorylation deficiency | 4.08e-03 | 37 | 257 | 3 | cv:C4540031 | |
| Disease | migraine disorder | 4.30e-03 | 357 | 257 | 9 | MONDO_0005277 | |
| Disease | depressive symptom measurement | BRINP3 CNTN5 ASCC3 MED12 TCF20 CRB1 SDR9C7 PRKAR2A ROBO1 PCDH7 | 4.41e-03 | 426 | 257 | 10 | EFO_0007006 |
| Disease | urinary bladder cancer (is_implicated_in) | 4.42e-03 | 76 | 257 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | dystonia (implicated_via_orthology) | 4.71e-03 | 12 | 257 | 2 | DOID:543 (implicated_via_orthology) | |
| Disease | cholesteryl ester 24:5 measurement | 4.71e-03 | 12 | 257 | 2 | EFO_0021448 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TET2 TSHZ2 NCAM2 BIRC6 DLG2 ASCC3 ADGRL2 PRRC2B AKAP6 TCF20 REV3L FIGN PCDH7 SORL1 PHACTR1 | 4.72e-03 | 801 | 257 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | mental or behavioural disorder | 4.95e-03 | 179 | 257 | 6 | EFO_0000677 | |
| Disease | Inherited neuropathies | 5.09e-03 | 40 | 257 | 3 | C0598589 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.10e-03 | 301 | 257 | 8 | DOID:684 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.22e-03 | 181 | 257 | 6 | DOID:684 (is_implicated_in) | |
| Disease | Renal Cell Carcinoma | 5.35e-03 | 128 | 257 | 5 | C0007134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SITGYGQTGPISQRA | 166 | Q9HAC7 | |
| KGEVPNGYNVSRSTT | 76 | A0A0A6YYG2 | |
| SGGTLRIYADSLKPN | 246 | P55196 | |
| VKQLLPSGNGRSYGL | 366 | Q9H2P0 | |
| KVTETRTGPLGCSNY | 206 | Q76B58 | |
| SRIKSNGPNGNESIY | 631 | Q76B58 | |
| YQLGTTQDPGTKDRI | 3436 | Q9NR09 | |
| PQGYRSIDLTVKLGS | 3996 | Q9NR09 | |
| LSKVPGYGLQVRNSD | 221 | Q9NXE8 | |
| AAVYNPSGLNLSIKG | 1006 | Q9H7T0 | |
| YLRVANGSSLVVPQG | 1126 | Q6UVK1 | |
| NVKYSSSQPEPRTGL | 311 | O14757 | |
| IPGSQKAALGYNILT | 146 | P07357 | |
| TPKGLTAYVSNEGRI | 136 | A5X5Y0 | |
| SLPVYKGEIQARNLG | 451 | Q86V21 | |
| GVLSKIGRSGENPYA | 131 | Q9UHK6 | |
| ENPVKYQGLGRLTFS | 296 | Q9Y276 | |
| RSVGKLESNLDGYVP | 66 | Q7LC44 | |
| PGSQTAVKNSNRYDV | 391 | Q9NWN3 | |
| RGPSGLLLYNGQKTD | 1671 | O00468 | |
| SQAGAEGQPSTVKRY | 771 | Q5H9F3 | |
| RYKGPSGTNIIIGSI | 726 | O75078 | |
| LQNYTGGNLTVTGPK | 126 | Q96PS8 | |
| QKGDTISCNVTYPGR | 661 | P53420 | |
| SRGNSDGYIIPINKE | 1426 | O95490 | |
| QDSSGKTPVDYARQG | 196 | Q14161 | |
| DQSKRVGYLTGLPTT | 561 | Q92625 | |
| GSLIIGYARNPSLKQ | 96 | Q06055 | |
| PNDTSLKNDLGVGYL | 451 | Q12797 | |
| DYIQNAPGLPKTRSG | 646 | Q9NR19 | |
| PLSLAASGGYVNIIK | 1186 | O75179 | |
| NQLGYTTPAERGRSS | 366 | Q96HY7 | |
| NIKYPGQRTTLTGLD | 186 | P23280 | |
| DKTYENVLSSRGPQN | 721 | Q49A88 | |
| SGPLGNSYVERQRSV | 641 | Q9UER7 | |
| GSLIIGYARNPSLKQ | 91 | P05496 | |
| ESYELPARSQIGQKS | 1416 | Q04656 | |
| ASSQIRVPSYSGGKI | 1056 | O94779 | |
| EPAQREQSTGQATKY | 421 | O95741 | |
| TNATSGGTPEQIRYL | 406 | O15131 | |
| AISRTSKTIYQGAGP | 881 | Q5TC82 | |
| FVNPGILGSLSSYRK | 476 | Q9Y620 | |
| YGGLKTPTQLEGATR | 401 | O94776 | |
| YIPGSNATLTNAAGK | 896 | Q9Y5G6 | |
| NLQTYIDKSTQLPGG | 271 | Q9H8K7 | |
| YIPGSNATLTNAAGK | 896 | Q9Y5H1 | |
| QVTSKTPIRLYGGAL | 96 | O14683 | |
| TNLYIRGLQPGTTDQ | 56 | Q15434 | |
| RKIQLGIDPYNAGSL | 241 | Q01201 | |
| YGIQRGDIVIAKSPS | 61 | Q96LU5 | |
| YIPGSNATLTNAAGK | 896 | Q9Y5G5 | |
| YIPGSNATLTNAAGK | 896 | O60330 | |
| INGKVSYRIQDSPVA | 491 | Q9NPG4 | |
| LDVGKNGVQNYTISP | 106 | Q96TA0 | |
| AAGIPSITAYSKNGL | 701 | O43747 | |
| YIPGSNATLTNAAGK | 926 | Q9Y5G9 | |
| KVVEGTAYGLSRSQP | 606 | P16234 | |
| TIKTNDPGVLQAARY | 41 | O76096 | |
| LGGDLGTYVINKQTP | 136 | Q16595 | |
| AYQNTALGRTILGPT | 201 | O75439 | |
| SQLTNGIKELGPYTL | 12481 | Q8WXI7 | |
| LSQLTNGIKELGPYT | 12636 | Q8WXI7 | |
| NGIKELGPYTLDRNS | 12641 | Q8WXI7 | |
| LSQLTNGIKELGPYT | 12791 | Q8WXI7 | |
| NGIKELGPYTLDRNS | 12796 | Q8WXI7 | |
| EKYSLPVVQNDSSRG | 6 | Q8NA72 | |
| YSDTPSGLVNGRKNE | 91 | Q5HY92 | |
| YIPGSNATLTNAAGK | 896 | Q9Y5G7 | |
| EGGPQRSNTYVIKLF | 86 | Q96GY3 | |
| QYGFLTTPTKQLGAQ | 1061 | P46821 | |
| PIGDYPSRAKISGQN | 371 | Q96JY0 | |
| PTLSRNKYGTGAVSI | 381 | Q4G0Z9 | |
| YDVKVQAINQLGSGP | 781 | O00533 | |
| EGSPETLTNLRKGYL | 136 | Q9P035 | |
| KGAIILYNRVQGSPT | 276 | Q9BRQ3 | |
| GQKLQGPQTSAEVYR | 296 | Q8N335 | |
| ATRKPQYEQLTAAGQ | 4676 | Q03001 | |
| VYVNGANSELKSSPR | 71 | O60303 | |
| PEDRIYLAGSSIKGQ | 26 | A6NEK1 | |
| TISPSKANYRPGENL | 241 | P40199 | |
| TIKGGRQSGAVLYNS | 1901 | Q2LD37 | |
| GRGKYRTISQIPQFT | 171 | Q9H252 | |
| VQVNGAATELRKPSY | 636 | Q92615 | |
| IYNISGNGSPLADSK | 211 | Q53HL2 | |
| LGYVSQQGGQRSTPL | 36 | Q9UK73 | |
| VTENPYRKSGQEASI | 261 | Q69YN2 | |
| PGNSRLNYTVLIGST | 1181 | Q9UIW2 | |
| KSPALGVDIVNYNSG | 231 | Q9NQ69 | |
| YIPGSNATLTNAAGK | 896 | Q9Y5G4 | |
| PGQIGGAVKLSISYR | 1556 | O00443 | |
| YIPGSNATLTNAAGK | 891 | Q9Y5G3 | |
| IVTVEASKPNGQRYD | 951 | O60245 | |
| PGNQILSGLSIEEYK | 696 | O76074 | |
| GKIQGQELSAYQAPS | 126 | Q96S96 | |
| GIGYTVGNLTSKPER | 36 | O14986 | |
| QGLRQPGSKYPDIAS | 1231 | Q8IVL0 | |
| RQSKISEVLGGSGYN | 656 | Q9Y2G0 | |
| INLYFGSKVRSPVSG | 56 | Q9BX51 | |
| KSYDRGQPIRSTDVG | 1221 | O75037 | |
| GSYGTAPVNLNIKTG | 111 | Q6UN15 | |
| AAALSVPGKREQYGS | 1021 | Q6AI08 | |
| APYNALTGKDSTRGV | 86 | Q9UMX5 | |
| KLQEIFSRGPYSVQG | 186 | Q7LBC6 | |
| SPEAVRAVGKLSYNQ | 246 | Q8N5J2 | |
| GLQEIKTIGYTSPRS | 991 | Q8IZD2 | |
| SKGIRGNEPVYTSTQ | 46 | Q9H8J5 | |
| YTGLGKSLSENPANR | 1036 | Q93074 | |
| YTLSPINGKISGVNA | 456 | Q9H223 | |
| PSGLRYNKLSLNEEG | 246 | Q9UI32 | |
| TGDVPIGIYRTESQK | 951 | Q6UVM3 | |
| GLTRVYPKGQRVDSS | 981 | P16885 | |
| GSRQLQLAVPGAYEK | 201 | Q68DD2 | |
| QPGTVALVRQDGYKL | 191 | Q8TAA5 | |
| LYSQVSGTPLQRIGS | 256 | P28290 | |
| TYGTQTRVSLALPGQ | 156 | Q6XUX3 | |
| QVYSSEPGNGAKDLL | 526 | Q02413 | |
| RGYTKSPNQLVTPAA | 286 | O95800 | |
| LGGKQPVYDTTIRTG | 6601 | Q9UPN3 | |
| YGAERGNLNGETIKS | 1821 | P78509 | |
| KLLQSDYLQGVPSNG | 36 | P49335 | |
| NSLYGPGTNRTTVNK | 196 | Q9UMY1 | |
| PDEGRNGKVTYSILS | 1646 | Q6V1P9 | |
| VGGPDLSLVSYTAQK | 251 | Q9C0D0 | |
| IGQSTIPLNSLKQGY | 716 | P51178 | |
| NPNYTGGEPKRSRTA | 146 | P09016 | |
| YIPGSNATLTNAAGK | 896 | Q9Y5H0 | |
| GYTSPKRLTINGGSN | 541 | P48147 | |
| IQGEYTLTLRKGGNN | 361 | O00459 | |
| SIGGLPNLSDEYKQI | 121 | Q9HB29 | |
| TGKSALDNGPQIAYV | 511 | Q96J02 | |
| SYLLSKREGQAGSPE | 666 | Q92794 | |
| DPQSKGIQTGRCVVY | 141 | Q99572 | |
| GIGYQSNKEQAPSDL | 106 | Q8N6G5 | |
| SKTLTQGGVTYRDQP | 166 | Q13643 | |
| SVPFENKLYLVGGQT | 461 | Q8NBE8 | |
| KAQYIPGAQAATRGL | 356 | Q96B18 | |
| EPGNYRTAILGKENL | 201 | Q8NEX9 | |
| RGGKYAATSQVLLPS | 61 | P01871 | |
| QGRPGLSLVKENYAE | 781 | P12109 | |
| YVSGNGKRIVLITPS | 121 | Q9H799 | |
| SLENVYRGSEGSPTK | 246 | Q9ULE3 | |
| LLPSDTGQGYRTVKA | 71 | Q9NPF5 | |
| GEKGEPQSLATLYQL | 1186 | Q9P218 | |
| VIEAVRNLPYKGGNT | 221 | Q05707 | |
| RNLPYKGGNTLTGLA | 226 | Q05707 | |
| ASGKGVNYIPSEERA | 1251 | Q14CM0 | |
| YQGPAKGAADTTIIL | 676 | P51659 | |
| NGDNGYSKILPSLIS | 596 | Q5T1B0 | |
| LEGKNLVYSAPTSAG | 106 | O75417 | |
| LRKVESLVNTNGGPY | 186 | Q8ND71 | |
| TVPESQKGALQGYRD | 251 | Q9BZC7 | |
| SNGYKGDTTPNLRLL | 1231 | Q12955 | |
| PLIKYLSATTGFGRN | 281 | P56937 | |
| KSLPGQNEDLVLTGY | 71 | P01040 | |
| QLQDAGPARTYKGSL | 121 | Q8N8R3 | |
| NPLERLGTGSAYEVK | 766 | Q6P0Q8 | |
| IQSSPGQRATLSGIY | 31 | O43638 | |
| LVTNKPRAASAYAVG | 341 | P13861 | |
| LGQIYPGASTGKINI | 61 | Q8IYD9 | |
| VYNRSSGLVSNAPGV | 106 | P04180 | |
| GLRVSVPLIAQGNSY | 601 | P11047 | |
| NYGNLVSLGLAVSKP | 36 | Q7Z2F6 | |
| LSGNNGTLEYKTSLP | 306 | Q15700 | |
| GNKYTLETRPNQEGI | 221 | P14735 | |
| GLEKDPQRSGDLYTQ | 681 | O00418 | |
| APQTLRSSGQTLVYG | 1791 | A6NE01 | |
| YATRKTPSVGSQGDQ | 21 | A2RUR9 | |
| ELSSEKQYGRITGLP | 356 | P82279 | |
| QGTYSPSRQEKEGSR | 1376 | P82279 | |
| VPKGSIGQYIQDRSV | 41 | Q9NQC7 | |
| TLKNPGRVAYDSGGI | 11 | A0A1B0GVR7 | |
| SSSKEENRIIPGGIY | 21 | P01036 | |
| TRLYNQPTDAQGKGL | 231 | Q3KQZ1 | |
| VNPSYNGGEPKRSRT | 206 | Q00056 | |
| GTYSEVSLAQDPKRQ | 6 | O43908 | |
| KGIPRYCSVTTQADG | 446 | O43781 | |
| IQNLSPRTGKAYTGA | 296 | A6NMZ7 | |
| QQKLLYPNSGREGTA | 106 | P15509 | |
| TQIPQAVGAAYAAKR | 211 | P12694 | |
| IYNKIPGTSNNGLEE | 521 | P18433 | |
| GGSGLSKSRLYPQAQ | 21 | Q9UJV8 | |
| LGQLVSGSRPSSQVY | 896 | Q9Y6K5 | |
| QQSPAGRVTLSGIYD | 46 | A0A1W2PRP0 | |
| GNEYDLTGLSTVRKP | 1091 | P11717 | |
| SSPGIGAVYLANQAK | 186 | Q96DX8 | |
| ALKPNQVGETSLYGV | 71 | P84550 | |
| SQPRLTYKTVSGVNG | 41 | P21281 | |
| NSTVEYTLNKLEPGG | 1986 | Q92673 | |
| GVQVYNSLTGRKEPL | 51 | Q9HA77 | |
| EEAQIGKRGYLTPTS | 246 | O95602 | |
| IGYQADIKGSSQPAS | 2171 | Q8WUY3 | |
| YASLLKRQLNGGPDV | 11 | Q15031 | |
| STRLYNQPVDTAGRG | 231 | Q6PIV7 | |
| TEVDEGSLNPGKQRY | 726 | Q2TB90 | |
| GYQRPGSVVAAKAQL | 791 | A6NI28 | |
| PQDTAYNTKRGIVAS | 86 | Q9BVG9 | |
| GQPYNQLAILASSKG | 186 | Q92540 | |
| TGQNREVSILYPGAK | 636 | Q8TE76 | |
| EVSILYPGAKDQRQG | 641 | Q8TE76 | |
| KLRGQTGIFPANYVT | 326 | Q96HL8 | |
| KYGINDNGTTEPRVL | 986 | O14802 | |
| VRTVQNSGYGPKLTS | 2071 | O75592 | |
| LPGNAGSYKQVRSIG | 91 | Q75T13 | |
| ATGYLGSVAAKRPLQ | 1346 | O95785 | |
| LPGGNRRNSTAKDYT | 156 | O95149 | |
| VINNGSPTILGKRSY | 571 | Q13330 | |
| SPTILGKRSYEQHNG | 576 | Q13330 | |
| PYATNEIGKVTGLNR | 431 | Q8TCS8 | |
| SSPENINNGKYILSG | 1906 | Q4LDE5 | |
| QVIYTRNTKGGDAPA | 106 | P62851 | |
| VTGEQYGRPISGQKE | 161 | Q99470 | |
| PYQRTLKEGQGTSVV | 41 | Q9UL12 | |
| RSKGPVVQYTQDLTG | 426 | Q15047 | |
| TRSNPLSLKGYGFQI | 71 | Q5VYV7 | |
| NGELSYTSKAIEGPQ | 531 | Q13023 | |
| GNSSLPTAGYKRAQT | 441 | P55197 | |
| PTAGYKRAQTSGIEE | 446 | P55197 | |
| LVPGSRGASNKYLVE | 11 | Q16186 | |
| NRLSPQDQGDYGTVK | 151 | Q53RT3 | |
| TPGGVENSYGKINIL | 1046 | Q8N3C0 | |
| SKPLYLGQTGLGNIE | 281 | Q70JA7 | |
| INALQDYGKRSLPGV | 111 | O75596 | |
| SGIPDGQLQAYRKEL | 216 | Q9NUQ7 | |
| KLFEVGGSPSNTRYL | 96 | P48454 | |
| DPTASGTKENYGLLR | 716 | Q5T4D3 | |
| AGGSLPYSIQTAEKQ | 456 | Q9NUW8 | |
| GASLREKYPGQTQGL | 426 | Q9UM82 | |
| KETGSRYVAQAGLEP | 41 | O94966 | |
| NPTRAQGYSGLSVKV | 1051 | P07996 | |
| GPNREGKIQVYTAAT | 326 | Q6ZTK2 | |
| QEGLTQTYAPSGRSL | 391 | Q5D1E8 | |
| YSGLNIVRPSTGKIV | 71 | Q14CS0 | |
| KRSQYPEIIFLGTGS | 476 | Q9BQ52 | |
| IRIYKISSGSQGAQG | 1951 | Q99973 | |
| LLSYSGQKTEGPQRI | 2816 | Q96T58 | |
| PNTTYEIRVAAVNGK | 561 | O15394 | |
| PEGRKGTISQYFTTL | 3026 | O60673 | |
| EQLTGQTPVFSKARY | 41 | P62913 | |
| LSVTGEQYGSPIRGQ | 171 | Q9HCN8 | |
| YTSANGETREVPVGK | 831 | Q9UQP3 | |
| LTKVVSQQPFVGYRG | 496 | Q9Y2P5 | |
| LDLPSQGYKREVSTG | 2256 | Q15413 | |
| VYFRQGVTPSELSGK | 356 | Q7Z6L1 | |
| AINQKLGDTPGVSYS | 506 | Q9H269 | |
| SQGVRNYSVPIGLDS | 116 | Q2M296 | |
| VNLNYRKGTGASQPD | 56 | Q9Y5S1 | |
| QTALPGNDRYISVGS | 71 | Q9UHP3 | |
| QYNSPQEVIGKRGSD | 431 | P11172 | |
| SGTVGRRSPELSYQN | 1351 | Q5JSZ5 | |
| DGSPRTGQIFKQTYS | 156 | P01241 | |
| DQTKYLTPGRGLQEF | 1186 | Q70Z35 | |
| NGLTSTYAGIRKVPS | 926 | Q9Y6N7 | |
| LGSGPPLRTAQYNSK | 266 | Q9P283 | |
| IIPKYGSINGATRLT | 36 | Q86WI1 | |
| EVSQGPGLLNDTKVY | 126 | P01833 | |
| DKVIPLYGRGSTGQQ | 86 | Q96GF1 | |
| TLPSSAAGYQLRVGQ | 216 | Q9UGU0 | |
| KGEVPNGYNVSRSNT | 76 | A0A0A0MS04 | |
| QTSEGKYLLSDLGPQ | 866 | Q9NRE2 | |
| LTRVQSYGPEDSKQG | 636 | Q5HYM0 | |
| TSPDVGGNDQSQYKR | 311 | P41587 | |
| VQYTLPKTAGGDRAD | 586 | Q07157 | |
| ARILLGEGPTNQKGY | 291 | Q9UHR6 | |
| GEGPTNQKGYTLAAL | 296 | Q9UHR6 | |
| NTPKYSQVLGLGGRI | 366 | P18887 | |
| GKRVENINGTSYPSL | 116 | Q8NB50 | |
| YATSSPGQRVQKGGT | 141 | Q92956 | |
| KSQGPLTVAAYQLGS | 816 | Q8TEQ8 | |
| SERTIQDSNYGGKIP | 286 | Q7Z2W7 | |
| GKDYIPINAILTGNS | 1166 | P17948 | |
| RESGTIQRYSLPNVG | 521 | Q9P2L0 | |
| QAPGGSSERYLKQNE | 361 | Q6N021 | |
| IKINGYTGPGTVRIS | 61 | Q04206 | |
| SKGSLIYGVTSPQRG | 36 | Q7Z2V1 | |
| KGEVPDGYSVSRANT | 76 | A0A1B0GX49 | |
| AERTGGTYSTLKVQP | 86 | A0A5B0 | |
| LFYIPSGTKQNGRLS | 66 | A0A0B4J277 | |
| RGKSYVQCQGIPQGS | 821 | O14746 | |
| KGEVPDGYNVSRSNT | 76 | A0A0J9YX75 | |
| SAGNIYQKRPVLGDI | 1276 | Q562E7 | |
| YGQNSIKRLLPGSSD | 401 | Q6ZT98 | |
| LRIKEEQVSPSQYGG | 226 | Q86UZ6 | |
| ARSIATGKNGYIPSN | 131 | P07947 | |
| NLYFGSKVRSPVSGI | 401 | P19440 | |
| NGTGRYTVVKGIISP | 36 | Q9HAN9 | |
| TLRAKPTGNGIYING | 491 | Q96NY8 |